ML19345B536

From kanterella
Jump to navigation Jump to search
Notice of Consideration of 801003 Application for Renewal of License R-84
ML19345B536
Person / Time
Site: Armed Forces Radiobiology Research Institute
Issue date: 11/18/1980
From: John Miller
Office of Nuclear Reactor Regulation
To:
Shared Package
ML19345B535 List:
References
NUDOCS 8012010535
Download: ML19345B536 (4)


Text

.

  • q, ye M?u fl

,0,,

UNITED STATES g

NUCLEAR REGUI.ATORY COMMISSION y ' {', +, (

.j WASHINGTON D.C.20555

%, *% /

'NOV 181980 Docket No.: 50-170 Captain Paul Taylor Armed Forces Radiobiology Research Institute National Naval Medical Center Bethesds, Maryland 20014

Dear Captain Taylor:

Enclosed is a copy of the " Notice of Consideration of Application for Renewal of Amended Facility License" which is being filed with the Office of the Federal Register for publication.. The notice relates to your application dated October 3, 1980 for a license amendment to renew Facility License No.

P-84 for your TRIGA-type reactor.

The expiration date for this license was November 8,1980.

Since your appli-cation had been submitted at least 30 days prior to the expiration date of your license, you have satisfied the requirements of 10 CFR Part 2, Section 2.109, entitled "Effect of Timely Renewal Application." Accordingly, pursuant to 10 CFR 2.109, the existing license will be deemed not to have expired until the application has been finally determined.

If you have questions regarding this matter, please contact us.

Sincerely, 0/ f.lf /

l 'o /

c j-l jn.., \\ - );l.' ' L " ')

~ = -

,.7 '

James R. Milldr, Chief Standardization & Special Projects Branch Division of Licensing

Enclosure:

Notice i

cc w/ enclosure:

See next page 8012o1o 5y

Armed Forces' Radiobiology Research NOV 181980 Institute cc w/ enclosures:

Director, Department of Sta*.e Planning

. 301 West Preston Street Director.

Department of Natural Resources Power Plant Siting Program Energy & Coastal Zone Administration Tawes State Office Building Annapolis, Maryland 21401 a

T l

~-.

7590-01 t

UNITED STATES NUCLEAR REGULATORY COMMISSION 00CXET NO.: 50-170 ARMED FORCES RADI0 BIOLOGY RESEARCH INSTITUTE (AFRRI)

NOTICE OF CONSIDERATION OF APPLICATION FOR RENEWAL OF AMENDED FACILITY LICENSE The United States Nuclear Regulatory Commission (the Comnission) is considering renewal of Facility License No. R-84, issued to the Armed Forces' Radiobiology Research Institute (AFRRI) (the licensee), 'Jr operation of the TRIGA-type research reactor located on the National Naval Medical Center site in Bethesda, Maryland.

The renewal would extend the expiration date of Facility License No.

R-84 to November 8, 2000, in accordance with the licensee's timely application for renewal dated October 3,1980.

Prior to a decision to renew the license, the Commission will hava made findings required by the Atomic Energy Act of 1954, as amended (the Act) and the Commission's regulations.

By MCC 9 41990

, the licensee may file a request for a hearing with respect to renewal of the subject facility license and any person whose interest may be affected by this proceeding and who wishes to participate as a party in the proceeding must file a written petition for leave to intervene.

Requests for a hearing and petitions for leave to inte-vene shall t2 filed in accordance with the Commission's " Rules of Practice for Domestic Licensing-Proceedings" in 10 CFR Part 2.

If a request for a hearing or petition for leave to intervene is fileo by the above date, the Commission or an Atomic Safety and Licensing Board,

1 7590-01

  • designated by the Commission or by the Chaiman of the Atomic Safety and Licensing Board Panel, will rule on the request and/or petition and the Secretary or the designated Atomic Safety and Licensing Board will issue a notice of hearing or an appropriate order.

As required by 10 CFR 5 2.714, a petition for leave to intervene shall set forth with particularity the interest of the petitioner in the i

proceeding, and how that interest may be affected by the results of the proceeding. The petition shoukd specifically explain the reasons why intervention sbnuld be permitted with particular reference to the following factors: (1) the nature of the petitioner's right under the Act to be made a party to the proceeding; (2) the nature and extent of the petitioner's property, financial, or other interest in the proceeding; and (3) the possible effect of any order which may be entered in the proceeding on the petitioner's interest. The petition should also identify the specific aspect (s) of the subject matter of the proceeding as to which petitioner wishes to intervene. Any person who has filed a petition for leave to intervene or who has been admitted as a party may amend the petition without requesting leave of the Board up to fifteen (15) days prior to the first prehearing conference scheduled in the proceeding but such an amended petition must satisfy the specificity requirements described above.

Not later than fifteen (15) days prior to the first prehearing conference scheduled in the proceeding, a petitioner shall file a

. supplement to the petition to intervene which must include a list of I

.s-7590-01

, the contentions which are sought to be litigated in the matter, and 4

the bases for each contention set forth with reasonable specificity.

Contentions shall be limited to matters within the scope of the renewal action under consideration. A petitioner who fails to file such a supplement ~which satisfies these requirements with respect to at least one contention will not be permitted to participate as a party.

Those permitted to intervene become parties to the proceeding, subject to any limitations in the order granting leave to intervene, and have the opportunity to participate fully in the conduct of the hearing, including the opportunity to present evidence and cross-examine witnesses.

i f

A request for a hearing or a petition for leave to intervene shall be filed with the Secretary of the Commission, United States Nuclear Regulatory Commission, Washington, D.C.

20555, Attention: Docketing and l

Service Section, or may be delivered to the Commission's public Document Room,1717 H Street, N.W., Washington, D.C. by the above date. Where petitions are filed during the last ten (10) days of the notice period, it is requested that the petitioner or representative for the petitioner promptly so inform the Commission. by a toll-free t:lephone call to Western Union at (800) 325-6000 (in Missouri (800) 324-6700). The

- Western Union ' operator should be given Datagram Identification Number 3737 and the following message addressed to James R. Miller:

(petitioner's name and teleohane number); (date petition was mailed); (Armed Forces Radiobiology Research Institute) and (publication date and page number of j

~

7590-01 this FEDERAL REGISTER notice). A copy of the petition should also be sent to the Executive Legal Director, U. S. Nuclear Regulatory Commissica, Washington, D.C.

20555, and to Captain Paul Taylor, Armed Forces Radio-biology Research Institute, National Naval Medical Center, Dethesda, Maryland 20014 Nontimely filings of petitions for leave to intervene, amended petitions, supplemental petitions and/or requests for hearing will not be entertained absent a determination by the Commission, the presiding officer or the Atomic Safety and Licensing Board designated to rule on the petition and/or request, that the petitioner has made a substantial showing of good cause for the granting of a late petition and/or request.

That determination will be based upon a balancing of the factors specified in 10 CFR i 2.714(a)(1)-(v) and s 2.714(d).

For further details with respect to this action, see the application for renewal dated October 3,1980, which is available for public inspection i

at the Commission's Public Document Room,1717 H Street, N.W., Washington, D.C.

20555.

th Dated at Bethesda, Maryland this 18 day of November 1980.

FORTHE)iUCLEARREGULATORYCOMMISSION Af'f.

/

8' gw%y-, ;x. :

~

,/ / James R. Miller, Chief f

Standardization & Special

/

Projects Branch Division of Licensing

.n

..., ~.-.,,-,-